CannTrust Reports Record Revenue for Q1 2018

CannTrust Reports Record Revenue for Q1 2018

VAUGHAN, ON, May 15, 2018 /CNW/ – CannTrust Holdings Inc. (“CannTrust” or the “Company” | TSX: TRST), a licensed producer of medical cannabis under the Health Canada Access to Cannabis for Medical Purposes Regulation (“ACMPR”) program, today announced financial and...

CANNTRUST

Since 2013, CannTrust has been delivering standardized products that enable physicians to provide accurate dosage to patients, similar to pharmaceuticals, all while rapidly building capacity and capability to expand into new categories: the adult use market, over-the-counter, natural healthcare products, pet care, and beauty.

SUBSCRIBE TO INVESTOR NEWSLETTER

Subscribe Now

FOLLOW US

© CannTrust 2019

Terms & Conditions

Pin It on Pinterest